Editorial policy
How we source and review information
Before any page here is published, it has to pass a set of rules. Whether you are looking into cancer biologic therapy trials for yourself or reading for someone you care for, what you find should be accurate, current and easy to check. Below, we explain where our information comes from and what those rules are.
Where our information comes from
When a page here explains how clinical research works, whether you are reading about cancer biologic therapy trials for yourself or for a relative, that explanation rests on published material from health agencies and research institutes of the U.S. government. Three of them are the Food and Drug Administration, the Office for Human Research Protections and the National Institutes of Health.
The sources behind a page are listed at its foot. Nothing gets linked unless we have opened it and checked it ourselves. Those links are checked again on a regular schedule.
How study listings are produced
Every study listing on this website, along with the counts shown beside it, is drawn from ClinicalTrials.gov. That is a public registry of studies, and the U.S. National Library of Medicine runs it. For each record, we display a portion just as the registry holds it, in the words it was registered with. There is no rewording on our side.
Only one kind of study is listed here: studies testing a biologic, for example a vaccine, an antibody, or a cell or gene therapy. We do not pick which studies count. The registry's own coding of each study decides that.
You, or a family member reading on someone's behalf, can judge how recent a listing is from the date printed on it, which is when its data were processed. For the latest information, the registry record for that study is always the place to go, and a link to it sits on each listing. Cancer Biologic Trials is not the one running these studies, and it has no affiliation with the sponsors behind them.
Rules every page must pass
- No page here says or hints that an investigational product works or is safe. Studies are done precisely because that is still unknown.
- We make no promise that you, or the person you are reading for, will benefit from joining a study or will turn out to be eligible.
- Payment is never the first thing we mention, and amounts are never published.
- We do not rush anyone into a decision.
- We do not offer medical advice.
The U.S. Food and Drug Administration has issued guidance on how study participants are recruited, and these rules are modeled on it. Before a page about cancer biologic therapy trials goes live, software tests it against every rule. A page that fails stays unpublished.
How pages are written
AI writing tools help draft the pages on this website. Those tools draw on the sources each page lists. Once a draft exists, software tests it against all the rules described above.
Corrections
Maybe a detail on this website strikes you, or the family member you are reading for, as out of date or simply wrong. Please tell us. We go back to the original source for each report we receive, and a page found to be mistaken gets fixed.
Who is responsible
Pioneer Research Group operates Cancer Biologic Trials. Learn more about us.
Sources and further reading
- Recruiting Study Subjects — Guidance for Institutional Review Boards and Clinical Investigators — U.S. Food and Drug Administration
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections